Clinical Trial Update: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial of MDMA-assisted psychotherapy for Posttraumatic Stress Disorder in 12 subjects was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2021-08-02